Effects of Neuromuscular Electrical Stimulation on Lower Limb Muscle Strength After Living Donor Liver Transplant: A Case-Control Study

•We investigate the effects of neuromuscular electrical stimulation (NMES) on lower limb muscle strength after living donor liver transplant.•There was no significant difference in changes between the NMES and non-NMES groups.•NMES did not show greater improvement of clinical outcomes in patients wi...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2022-04, Vol.54 (3), p.749-754
Main Authors: Hattori, Keiko, Mizuno, Yota, Ogura, Yasuhiro, Inoue, Takayuki, Nagaya, Motoki, Jobara, Kanta, Kurata, Nobuhiko, Nishida, Yoshihiro
Format: Article
Language:English
Subjects:
Activities of Daily Living
Adult
Case-Control Studies
Electric Stimulation
Humans
Liver Transplantation - adverse effects
Living Donors
Lower Extremity
Muscle Strength - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•We investigate the effects of neuromuscular electrical stimulation (NMES) on lower limb muscle strength after living donor liver transplant.•There was no significant difference in changes between the NMES and non-NMES groups.•NMES did not show greater improvement of clinical outcomes in patients with living donor liver transplant. Early mobilization after liver transplant (LT) plays an important role in postoperative recovery and complication prevention; however, patients undergoing LT cannot achieve early mobilization because of mechanical ventilation and poor preoperative physical performance. We investigated the effect of neuromuscular electrical stimulation (NMES) on lower limb muscle strength after living donor liver transplant (LDLT). Adult patients who underwent LDLT between December 2016 and January 2019 at a university hospital were recruited. A consecutive series of patients who underwent LDLT without NMES therapy before the clinical trial (April 2014-May 2016) were enrolled as the non-NMES (control) group. Patients in the NMES group received NMES on the quadriceps muscles starting 1 day post LDLT for 4 weeks. The study was conducted in accordance with the Declaration of Helsinki, and all patients provided informed consent. Twenty-four patients in the NMES group and 16 patients in the non-NMES group were analyzed. There was no significant difference between groups regarding changes in any outcome. The application of NMES in patients with LDLT did not yield greater improvement of muscle strength, functional capacity, activities of daily living, or length of hospital stay 4 weeks postoperatively compared with the control group. However, developing a novel NMES device and confirming whether additional NMES is effective for other body areas may yield different results.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2022.01.028